Perceptive Advisors’s Apyx Medical APYX Stock Holding History

Perceptive Advisors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-150,000	Closed	-$321K	–	118
2025 Q3	$321K	Hold	150,000	–	–	0.01%	89
2025 Q2	$338K	Hold	150,000	–	–	0.01%	81
2025 Q1	$206K	Hold	150,000	–	–	0.01%	85
2024 Q4	$237K	Buy	+150,000	New	+$210K	0.01%	97
2016 Q4	–	Sell	-48,544	Closed	-$253K	–	185
2016 Q3	$253K	Buy	+48,544	New	+$157K	0.02%	156
2016 Q2	–	Sell	-162,700	Closed	-$272K	–	177
2016 Q1	$272K	Hold	162,700	–	–	0.02%	145
2015 Q4	$342K	Hold	162,700	–	–	0.03%	106
2015 Q3	$322K	Sell	162,700 -10,000	-6%	-$22.9K	0.03%	116
2015 Q2	$482K	Sell	172,700 -27,300	-14%	-$75.1K	0.03%	132
2015 Q1	$478K	Buy	+200,000	New	+$665K	0.04%	116

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Perceptive Advisors's APYX Position: Q4 2025 in Review

Perceptive Advisors sold out of Apyx Medical (APYX) in Q4 2025, closing a stake of 150,000 shares — an estimated $321K sold.

Perceptive Advisors first reported a position in APYX in Q1 2015 and held it in 10 quarters. The position peaked at $482K in Q2 2015. 59 funds tracked by Wall St. Rank hold APYX as of Q4 2025.

Perceptive Advisors reported no remaining Apyx Medical position as of Q4 2025 after selling out during the quarter.
Perceptive Advisors sold 150,000 Apyx Medical shares in Q4 2025, an estimated $321K.
Perceptive Advisors first reported a position in Apyx Medical in Q1 2015 and held it in 10 quarters.
Perceptive Advisors's Apyx Medical position peaked at $482K in Q2 2015.
59 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2025.

Based on Perceptive Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.